Sign In
Buy ABSI
$5.94
-0.410 (-6.46%)
At Close: Jun 03, 2026
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
06:00am, Wednesday, 06'th Oct 2021
CAMBRIDGE, Mass., & VANCOUVER, Wash.--(BUSINESS WIRE)--EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices,
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Absci Corporation - ABSI
04:59pm, Tuesday, 21'st Sep 2021
New York, New York--(Newsfile Corp. - September 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Absci Corporation ("Absci" or the "Company") (NASDAQ: ABSI). Such investors
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Absci Corporation - ABSI
12:28am, Monday, 20'th Sep 2021
NEW YORK, Sept. 20, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Absci Corporation ("Absci" or the "Company") (NASDAQ: ABSI).
Absci to Participate in the BofA Securities 2021 Tech Solutions for Drug Discovery Conference
04:05pm, Monday, 13'th Sep 2021
VANCOUVER, Wash., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic po
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Absci Corporation - ABSI
09:23pm, Thursday, 09'th Sep 2021
NEW YORK, Sept. 9, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Absci Corporation ("Absci" or the "Company") (NASDAQ: ABSI).
Absci Reports Second Quarter 2021 Financial and Operating Results
08:30am, Tuesday, 07'th Sep 2021
VANCOUVER, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic po
Shares of protein discovery platform Absci pop in market debut
02:27pm, Thursday, 22'nd Jul 2021
Absci Corp., a Vancouver company behind a multi-faceted drug development platform, went public on Thursday. It's another sign of snowballing interest in new approaches to drug development – a tradit
Couchbase and 5 Other Companies Are Going Public. What You Need to Know.
01:05pm, Thursday, 22'nd Jul 2021
Couchbase, Ryan Specialty Group, and four other companies are scheduled to list their shares Thursday as the surge of IPOs continues.
IPO Day With Absci CEO Sean McClain - The Google Of Synthetic Biology (Video)
12:15pm, Thursday, 22'nd Jul 2021
Absci, a synthetic biology company whose platform technology aids in the drug discovery process, is going public today.
Absci Announces Pricing of Initial Public Offering
07:03pm, Wednesday, 21'st Jul 2021
VANCOUVER, Wash., July 21, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (“Absci”), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced
AbSci Proposes Terms For $200 Million IPO
01:12pm, Tuesday, 20'th Jul 2021
AbSci Proposes Terms For $200 Million IPO
